Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial
Author(s) -
Crystal Cooper,
Cherise R. Chin Fatt,
Manish K. Jha,
Gregory A. Fonzo,
Bruce D. Grannemann,
Thomas Carmody,
Aasia Ali,
Sina Aslan,
Jorge Almeida,
Thilo Deckersbach,
Maurizio Fava,
Benji T. Kurian,
Patrick J. McGrath,
Melvin G. McInnis,
Ramin V. Parsey,
Myrna M. Weissman,
Mary L. Phillips,
Hanzhang Lu,
Amit Etkin,
Madhukar H. Trivedi
Publication year - 2019
Publication title -
eclinicalmedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.915
H-Index - 20
ISSN - 2589-5370
DOI - 10.1016/j.eclinm.2019.04.007
Subject(s) - medicine , sertraline , placebo , major depressive disorder , perfusion , placebo response , clinical trial , psychiatry , cardiology , antidepressant , alternative medicine , pathology , amygdala , hippocampus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom